CompletedPhase 3NCT00319020
Bosentan in Children With Pulmonary Arterial Hypertension Extension Study
Studying Idiopathic/heritable pulmonary arterial hypertension
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Actelion
- Principal Investigator
- Andjela Kusic-Pajic, MDActelion
- Intervention
- Bosentan(drug)
- Enrollment
- 33 enrolled
- Eligibility
- 2-11 years · All sexes
- Timeline
- 2005 – 2011
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00319020 on ClinicalTrials.gov